Ryman Healthcare Limited (NZE:RYM)
New Zealand · Delayed Price · Currency is NZD 2.140
-0.050 (-2.28%)
Jul 31, 2026, 5:00 PM NZST
Ryman Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 798.49 | 713.8 | 650.53 | 560.11 | 503.76 |
Other Revenue | 55.99 | 45.37 | 37.03 | 21.5 | 5 |
| 854.47 | 759.16 | 687.56 | 581.61 | 508.76 | |
Revenue Growth | 12.55% | 10.41% | 18.22% | 14.32% | 11.64% |
Cost of Revenue | 773.69 | 751.09 | 711.92 | 542.16 | 466.24 |
Gross Profit | 80.78 | 8.07 | -24.36 | 39.45 | 42.52 |
Operating Expenses | 42.55 | 48.46 | 45.99 | 37.72 | 35.7 |
Operating Income | 38.22 | -40.39 | -70.34 | 1.74 | 6.82 |
Interest Expense | -123.72 | -142.78 | -69.05 | 3.91 | -30.66 |
Interest & Investment Income | 1.12 | 1.53 | 2.33 | 2.14 | 0.04 |
Currency Exchange Gain (Loss) | - | - | - | -24.41 | - |
Other Non Operating Income (Expenses) | 7.26 | -10.94 | -10.41 | -197.66 | - |
EBT Excluding Unusual Items | -77.12 | -192.58 | -147.48 | -214.27 | -23.8 |
Asset Writedown | -100.49 | -80.68 | -135.63 | 420.47 | 745.89 |
Other Unusual Items | - | -19.04 | 1.18 | - | - |
Pretax Income | -177.61 | -292.31 | -281.93 | 206.2 | 722.08 |
Income Tax Expense | -6.27 | 221.44 | -112.26 | -51.64 | 29.21 |
Net Income | -171.35 | -513.75 | -169.67 | 257.84 | 692.87 |
Net Income to Common | -171.35 | -513.75 | -169.67 | 257.84 | 692.87 |
Net Income Growth | - | - | - | -62.79% | 63.78% |
Shares Outstanding (Basic) | 1,016 | 710 | 688 | 516 | 500 |
Shares Outstanding (Diluted) | 1,016 | 710 | 688 | 516 | 500 |
Shares Change | 43.02% | 3.28% | 33.18% | 3.26% | - |
EPS (Basic) | -0.17 | -0.72 | -0.25 | 0.50 | 1.39 |
EPS (Diluted) | -0.17 | -0.72 | -0.25 | 0.50 | 1.39 |
EPS Growth | - | - | - | -63.96% | 63.78% |
Free Cash Flow | 281.88 | 272.38 | 393.44 | 219.01 | 251.68 |
Free Cash Flow Per Share | 0.28 | 0.38 | 0.57 | 0.42 | 0.50 |
Dividend Per Share | - | - | - | 0.088 | 0.224 |
Dividend Growth | - | - | - | -60.71% | 0% |
Gross Margin | 9.45% | 1.06% | -3.54% | 6.78% | 8.36% |
Operating Margin | 4.47% | -5.32% | -10.23% | 0.30% | 1.34% |
Profit Margin | -20.05% | -67.67% | -24.68% | 44.33% | 136.19% |
Free Cash Flow Margin | 32.99% | 35.88% | 57.22% | 37.66% | 49.47% |
EBITDA | 77.92 | 4.19 | -38.74 | 24.34 | 34.74 |
EBITDA Margin | 9.12% | 0.55% | -5.63% | 4.18% | 6.83% |
D&A For EBITDA | 39.7 | 44.58 | 31.6 | 22.6 | 27.92 |
EBIT | 38.22 | -40.39 | -70.34 | 1.74 | 6.82 |
EBIT Margin | 4.47% | -5.32% | -10.23% | 0.30% | 1.34% |
Effective Tax Rate | - | - | - | - | 4.04% |
Revenue as Reported | 855.59 | 760.7 | 689.89 | 583.75 | 1,255 |